Objective-Thioredoxin-1 (Trx-1), one important antioxidative enzyme in endothelial cells, is required for apoptosis inhibition.
T he thioredoxin system consists of 2 antioxidant oxidoreductase enzymes, thioredoxin-1 (Trx-1) and the thioredoxin reductase 1. Trx-1 is a small, 12-kDa, ubiquitous protein with 2 redox-active cysteine residues in an exposed active center, having the exact same amino acid sequence as Escherichia coli Trx, -Cys-Gly-Pro-Cys-(Cys32 and Cys35 within human Trx-1), which is essential for its redox regulatory function. 1 Therefore, this site is conserved among species from bacteria to humans. [1] [2] [3] Genetic targeting of Trx-1 leads to a lethal phenotype in mice. 4 The physiological functions of Trx-1 in different types of organisms have evolved from a common fundamental reaction to a large number of different specialized functions. Trx-1 regulates apoptosis, cell growth, differentiation, migration, angiogenesis, tumorigenesis, and development. 5, 6 Besides its enzymatic activity as an oxidoreductase, Trx-1 directly interacts with other proteins. 7 The interaction partners of Trx-1 can be subdivided in different classes of proteins depending on the cellular localization of Trx-1 itself. In the nucleus, Trx-1 binds directly to different transcription factors and thereby modulates their DNA-binding activity, eg, p53, nuclear factor-B, and activator protein 1. 8 -13 With respect to apoptosis inhibition, only the apoptosis signaling kinase 1 (ASK-1) and the thioredoxin-interacting protein (TXNIP) have been described. 14 -21 By binding to ASK-1, Trx-1 protects cells from apoptosis. Oxidation of Trx-1 results in loss of ASK-1 binding. 17 Moreover, interaction of Trx-1 with TXNIP inhibits the antiproliferative function of the latter in vascular smooth muscle cells, suggesting a proapoptotic function for TXNIP. 21 The aim of the present study was to identify new Trx-1 interaction partners, which could provide further insights into the protection of Trx-1 from degradation and, thus, into its antiapoptotic functions in endothelial cells. Here, we discovered actin as a new binding partner for Trx-1. The Trx-1-actin complex did not contain ASK-1. Thus, at least 2 different pools of Trx-1 exist, one binding to actin and the other one interacting with ASK-1. Both of them are required to protect endothelial cells from apoptosis. Moreover, interaction with Trx-1 inhibited H 2 O 2 -induced rigid bundle (socalled stress fiber) formation of actin, Trx-1 degradation, and thereby apoptosis induction in endothelial cells. Interestingly, once stress fibers have been formed, Trx-1 degradation and apoptosis induction cannot be blocked anymore. Therefore, the Trx-1-actin interaction seems to result in a mutual protection of the 2 proteins.
Materials and Methods

Cell Culture
Human primary endothelial cells (ECs) were cultured in endothelial basal medium supplemented with hydrocortisone (1 g/mL), bovine brain extract (12 g/mL), gentamicin (50 g/mL), amphotericin B (50 ng/mL), epidermal growth factor (10 ng/mL), and 10% fetal calf serum (Lonza, Cologne, Germany). After detachment with trypsin, cells were grown for at least 18 hours as described previously. 22, 23 
Plasmids and Transfection
Human Trx-1 was cloned out of endothelial cell-derived cDNA as described previously and inserted in pcDNA 4 (Invitrogen, Karlsruhe, Germany) or in the FLAG vector (Sigma-Aldrich, Munich, Germany). 24 ECs were transiently transfected with Superfect (Qiagen, Hilden, Germany) as described previously. 24 
Immunoprecipitation and Immunoblotting
Lysates (500 g) were immunoprecipitated with 5 g of the respective antibody overnight at 4°C. After incubation with protein A and protein G-Sepharose (GE Healthcare, Munich, Germany) for 2 hours at 4°C, the resulting beads were washed and boiled in SDS-PAGE sample buffer, and proteins were resolved by SDS-PAGE. Immunoblotting was performed with antibodies directed against Trx-1 (1:500, overnight, 4°C, BD Biosciences, Karlsruhe, Germany), ␥-actin (1:500), GAPDH (1:8000), ASK-1 (1:250) (overnight 4°C, Santa Cruz Biotechnology, Heidelberg, Germany), and phospho-focal adhesion kinase (phospho-FAK) (Tyr397) (1:250), FAK (1:1000) (both overnight 4°C, New England Biolabs, Frankfurt, Germany). Semiquantitative analyses were performed on scanned immunoblots using ImageJ 1.42q. 25 Mass Spectrometry analysis was performed on gel isolated proteins by the Proteome Factory (Berlin, Germany).
Immunostaining
Cells were fixed in 4% paraformaldehyde and permeabilized using 0.3% Triton X-100 and 3% bovine serum albumin in PBS. For immunostaining, cells were incubated with an antibody against Trx-1 and Xpress (both 1:50, Invitrogen, Karlsruhe, Germany) overnight at 4°C and stained with anti-rabbit or anti-mouse Alexa Fluor 488 -coupled antibodies (Invitrogen). Actin was stained with Alexa Fluor 568 phalloidin (1:500, Invitrogen) at room temperature for 20 minutes. Nuclei were counterstained with 4Ј,6-diamidino-2-phenylindole (1:2000, Invitrogen). Cells were visualized using an Axiovert 40 microscope from Zeiss (magnification, ϫ40, oil, Jena, Germany).
Detection of Cell Death by Fluorescence-Activated Cell Sorting
Detection of cell death was performed by fluorescence-activated cell sorting (FACS) analysis using annexin V-APC binding and 7 amino-actinomycin D (7-AAD) staining (BD Pharmingen, Heidelberg, Germany). In brief, cells were trypsinized of the dish and pelleted. After washing twice with annexin binding buffer cell pellets were resuspended in annexin binding buffer and incubated with 2.5 ng/mL annexin V-APC and 2.5 ng/mL 7-AAD for 20 minutes and analyzed using FACS.
Statistics
Statistical analyses were performed with the Student t test or Wilcoxon test using WinSTAT 2008.
Results
Actin Is a New Interaction Partner of Trx-1
We described previously that Trx-1 acts antioxidatively and is required to protect ECs from apoptosis. 22, 24, 26 Oxidative stress-induced stress fiber formation has been demonstrated to induce apoptosis. 27 Therefore, we hypothesized that a potential connection between Trx-1 and actin exists. Using Trx-1 immunoprecipitation combined with mass spectrometry, we identified actin as a new binding partner for Trx-1 ( Figure 1A ). It has been previously suggested that apoptosis of endothelial cells requires cytoskeletal rearrangements. 28 Thus, an interaction between Trx-1 and actin could be involved in the antiapoptotic function of Trx-1. Using the reciprocal immunoprecipitation approach, we could identify Trx-1 in immunoprecipitates obtained with an anti-␥-actin antibody ( Figure 1B) . A known interaction partner of Trx-1 is ASK-1. The preservation of the Trx-1/ASK-1 complex is Immunoprecipitates were subjected to SDS-PAGE, and a dominant band of approximately 37 kDa was extracted. Mass spectrometry revealed 6 peptides completely matching human actin. B, The reciprocal immunoprecipitation was performed using an anti-␥-actin antibody. Trx-1 was coimmunoprecipitated with ␥-actin, but ASK-1 did not form a complex with ␥-actin. IgG served as a negative control. Top shows an immunoblot with an anti-actin antibody; middle, immunoblot with an anti-Trx-1 antibody; bottom, immunoblot with an anti-ASK-1 antibody. SN/IP indicates supernatant of immunoprecipitation. C, Cell lysates used in B were also subjected to an immunoprecipitation with an anti-ASK-1 antibody. ASK-1 did not form a complex with ␥-actin. Top, immunoblot with an anti-ASK-1 antibody; bottom, immunoblot with an antiactin antibody. IgG served as a negative control. D, Immunostainings were performed to visualize Trx-1 (green); actin was stained with Alexa Fluor 568 phalloidin (red) and nuclei with 4Ј,6-diamidino-2-phenylindole (DAPI) (blue). The merge revealed that Trx-1 colocalizes with nonpolymerized actin (yellow). E, ECs were incubated with dimethyl sulfoxide (DMSO) as solvent or with 0.1 mol/L cytochalasin D (CytD) for 30 minutes. Trx-1 was immunoprecipitated out of EC lysates. IgG served as a negative control. Lysate corresponds to untreated total endothelial cell lysates before immunoprecipitation. Top, immunoblot with an anti-actin antibody; middle and bottom, immunoblots with an anti-Trx-1 antibody (long exposure, middle blot; short exposure, lower blot).
required to protect endothelial cells from apoptosis. 16 Thus, we wanted to know whether ASK-1 is also part of the Trx-1-actin complex. Interestingly, we did not find ASK-1 associated with actin, demonstrating that at least 2 different pools of Trx-1 exist in endothelial cells ( Figure 1B) , one binding to actin and the other one to ASK-1. We also performed the reciprocal approach, but we did not find actin in a complex with ASK-1 after immunoprecipitation with an ASK-1 antibody ( Figure 1C) . In a second approach, we used immunofluorescence and found that Trx-1 colocalized with actin. Interestingly, costaining was observed predominantly with nonpolymerized actin ( Figure 1D ). To further strengthen this observation, we incubated endothelial cells with cytochalasin D, a known interrupter of actin fiber formation. Indeed, incubation of endothelial cells with cytochalasin D for 30 minutes increased the association of Trx-1 with actin, demonstrating that Trx-1 interacts predominantly with nonpolymerized actin ( Figure 1E and Supplemental Figure I , available online at http://atvb.ahajournals.org).
Overexpression of Trx-1 Inhibits Stress Fiber Formation and FAK Phosphorylation
Because it is known that oxidative stress-induced bundle formation of actin leads to actin polymerization and so-called stress fibers, we next investigated whether Trx-1 can inhibit stress fiber formation. Incubation with H 2 O 2 induced bundle formation of actin after only 1 hour, and overexpression of Trx-1 completely blocked these cytoskeletal changes (Figure 2A ). Because polymerization of actin requires activation of FAK by phosphorylation, 29 we incubated ECs with the FAK inhibitor PF573228 for 6 hours before 1 hour of H 2 O 2 treatment. This preincubation inhibited stress fiber formation ( Figure 2B ). Interestingly, FAK inhibition in Trx-1 overexpressing ECs did not change the phenotype compared with PF573228 treatment ( Figure 2B , lower left panel) or overexpression of Trx-1 (Figure 2A) alone. In line with this finding, treatment of ECs with H 2 O 2 for 1 hour induced phosphorylation of FAK, which was completely blocked by preincubation with PF573228 for 6 hours ( Figure 3A and 3B). Preincubation with exogenous human Trx-1 for 6 hours also inhibited phosphorylation of FAK, but no additive effects were observed when ECs were coincubated with PF573228 and Trx-1 ( Figure 3A and 3B) , suggesting a common pathway.
Inhibition of FAK Prevents H 2 O 2 -Induced Trx-1 Degradation and Apoptosis in ECs
We next investigated whether actin bundle formation plays a role in endothelial cell apoptosis induction. H 2 O 2 induced apoptosis in ECs ( 22, 24 and Figure 4A ). Preincubation with PF573228 for 6 hours significantly inhibited H 2 O 2 -induced stress fiber formation and apoptosis ( Figure 4A and 4B) . We have previously shown that H 2 O 2 decreases Trx-1 protein levels and does not change Trx-1 mRNA levels. 22, 26 Therefore, we hypothesized that inhibition of nonphysiological, high activation of FAK might stabilize Trx-1. Indeed, preincubation with PF573228 for 6 hours reduced H 2 O 2 -induced Trx-1 degradation ( Figure 4C and 4D) . Thus, stress fiber formation seems to be a prerequisite for Trx-1 degradation and endothelial cell apoptosis induction.
H 2 O 2 -Induced Stress Fiber Formation Is a Prerequisite for Trx-1 Degradation and Endothelial Cell Apoptosis Induction
To analyze the sequence of events during apoptosis induction, we set up experiments in which stress fiber formation was induced before FAK inhibition. Therefore, we pretreated ECs for 1 hour with H 2 O 2 , continued incubation for 17 hours in the presence or absence of PF573228, and analyzed stress fiber formation, Trx-1 protein levels, and apoptosis. Interestingly, this postincubation with PF573228 did not inhibit H 2 O 2 -induced apoptosis ( Figure 5A ). This was because incubation with PF573228 after H 2 O 2 treatment inhibited neither stress fiber formation ( Figure 5B ) nor degradation of Trx-1 protein ( Figure 5C and 5D ). Based on our observations that Trx-1 interacts predominantly with nonpolymerized actin ( Figure 1D and 1E and Supplemental Figure I ), these data suggest that disruption of Trx-1-actin interactions by induction of actin polymerization with H 2 O 2 exposes Trx-1 and, thus, enhances its degradation.
Discussion
The data from our present study reveal actin as a new binding partner for Trx-1. Interaction of Trx-1 predominantly occurs with nonpolymerized actin. Inhibition of nonphysiological, high FAK phosphorylation and thus activation before H 2 O 2 treatment inhibited stress fiber formation, Trx-1 degradation, and apoptosis induction. In contrast, blockade of FAK activity after preincubation with H 2 O 2 did not prevent stress fiber formation, Trx-1 degradation, and apoptosis induction, demonstrating that the interaction with actin protects Trx-1 from degradation and thereby ECs from apoptosis induction.
Trx-1 is a multifunctional protein that has been demonstrated to induce transcriptome changes by interacting with several transcription factors and thereby modulating their functions. 30 With respect to apoptosis induction in vascular cells in vitro and in vivo, it has been shown that Trx-1 interacts with ASK-1 and thereby inhibits its proapoptotic action. [15] [16] [17] 31 Another binding partner for Trx-1, which has antiproliferative and proinflammatory properties, is TXNIP. 14, 18, 20, 21, 31 Inhibition of TXNIP-Trx-1 interaction or reducing TXNIP expression in vascular cells, including endothelial and vascular smooth muscle cells, increases Trx-1 activity and also reduces ASK-1 activation, probably by binding of Trx-1 to ASK-1. 31 One of the recently described pathways to reduce TXNIP expression is steady laminar flow, the most potent antiinflammatory and antiapoptotic stimulus for endothelial cells, which seems to make more reduced Trx-1 available in endothelial cells. 31 Our data now identify actin as a new physiological binding partner for Trx-1 in endothelial cells. Recently, overexpressed Trx-1 has been shown to associate with actin in tumor cells. 32 Interestingly, Trx-1 and actin do not form a trimeric complex with ASK-1 in endothelial cells. These findings suggest that at least 2 different pools of Trx-1 exist, one binding to actin and another one binding to ASK-1. Under conditions of oxidative stress, Trx-1 is released out of both complexes, leading to stress fiber formation and ASK-1 activation, which subsequently result in the induction of endothelial cell apoptosis (findings here and 15 ). Actin has been demonstrated to be essential for effects induced by steady laminar flow, as cytoskeletal rearrangements are necessary for signal transduction. 33 On the contrary, formation of rigid actin bundles (so-called stress fibers) is observed during apoptosis. 27 Therefore, it is tempting to speculate that laminar flow increases Trx-1-actin interactions as one new mechanism to inhibit stress fiber formation, to allow cytoskeletal changes and thereby to protect against apoptosis induction. This hypothesis is also underscored by the finding that impaired migratory capacity correlates with robust stress fiber formation, 34 which interferes with the dynamic reorganization of the actin cytoskeleton required for migrating cells. 35, 36 Furthermore, under conditions of oxidative stress, misassembled focal adhesion complexes and stress fibers are formed, leading to intense membrane blebbing, a hallmark of apoptosis. 27 These data suggest that drastic actin bundle formation induced by oxidative stress marks cells for the apoptotic process. In this study, we found that treatment with H 2 O 2 induces stress fibers, and once the fibers have been formed, the cell will undergo apoptosis. Because Trx-1 interacts predominantly with nonpolymerized actin, one could speculate that Trx-1 protects actin from polymerization by direct interaction. Thus, the Trx-1-actin interaction may protect endothelial cells from stress fiber-dependent apoptosis induction by preventing a misassembly of focal adhesions and, thus, induction of membrane blebbing. Of note, inhibition of stress fiber formation also resulted in reduced Trx-1 degradation. As Trx-1 is degraded by cathepsin D in lysosomes under conditions of oxidative stress, 22 the interaction of Trx-1 with nonpolymerized actin might not allow its transport to these organelles. Therefore, the Trx-1-actin interaction seems to result in a mutual protection of the 2 proteins.
Another potential mechanism of how stress fiber formation could be inhibited is the S-nitros(yl)ation of actin. It has been observed in different cell types that S-nitros(yl)ation of actin reduces its polymerization and thereby leads to shorter actin filaments. 37, 38 Because Trx-1 can also be S-nitros(yl)ated in endothelial cells, 24 a transnitros(yl)ation from Trx-1 to actin may occur, which in turn could prevent rigid bundle formation of actin. An involvement of actin in transnitros(yl)ation has already been investigated by Dalle-Donne et al, who reported that S-nitros(yl)ated actin acts as nitric oxide (NO) donor, showing a fast and potent vasodilating activity already at extremely low concentrations, suggesting that NO can indeed shuttle from S-NO to SH groups. 37 Taking our data together, we present here for the first time evidence that actin, as a new binding partner for Trx-1 in endothelial cells, protects Trx-1 from degradation. Oxidative stress induces stress fiber formation, followed by Trx-1 degradation and apoptosis induction in endothelial cells. Stress fiber formation is required for Trx-1 degradation and apoptosis induction. The Trx-1-interaction protects Trx-1 from degradation and actin from enhanced bundle/stress fiber formation. Thus, maintaining the Trx-1-actin interaction is one prerequisite to protect endothelial cells from apoptosis. A, Apoptosis rates were determined by FACS analysis using annexin V-APC binding and 7-amino-actinomycin (7AAD) staining (nϭ3). n.s. indicates not significant; con, control. B, Actin was stained with Alexa Fluor 568 phalloidin (red), and nuclei were counterstained with 4Ј,6-diamidino-2-phenylindole (DAPI) (blue). C, Trx-1 and GAPDH levels were assessed by Western blotting. D, Trx-1 and GAPDH were evaluated densitometrically. Shown is the ratio between Trx-1 and GAPDH (nϭ4, *PϽ0.05 versus control).
